BACKGROUND: Chronic inflammation is implicated in idiopathic pulmonary fibrosis (IPF) pathogenesis and is associated with persistent activation of immune responses. These are largely controlled by dendritic cells (DCs). Although large numbers of DCs infiltrate the lungs of patients with IPF, there are no similar reports in bronchoalveolar lavage fluid (BALF). OBJECTIVES: We aimed to investigate DC populations in BALF of IPF patients. METHODS: CD1c(+) myeloid DCs, BDCA3(high) myeloid DCs, BDCA2(+) plasmacytoid DCs and CD83(+) mature DCs were identified by flow cytometry in the BALF of 10 IPF patients and 10 controls. DC numbers were expressed as percentages of total BALF leukocytes. RESULTS: CD1c(+) myeloid DCs were increased in IPF patients versus controls [median (ranges in parentheses) 1.16% (0.25-3.97) vs. 0.61% (0.19-1.10), p = 0.01]. There was also a trend towards increased BDCA3(high) myeloid DCs [0.57% (0.23-0.88) vs. 0.28% (0.07-0.96), p = 0.07]. No differences were reported in BDCA2(+) DCs and CD83(+) DCs between IPF patients and controls. CONCLUSIONS: IPF is associated with an increase in percentages of BALF myeloid DCs. Considering that such an increase was not observed in CD83(+) mature DCs, most of these DCs should be immature.
BACKGROUND:Chronic inflammation is implicated in idiopathic pulmonary fibrosis (IPF) pathogenesis and is associated with persistent activation of immune responses. These are largely controlled by dendritic cells (DCs). Although large numbers of DCs infiltrate the lungs of patients with IPF, there are no similar reports in bronchoalveolar lavage fluid (BALF). OBJECTIVES: We aimed to investigate DC populations in BALF of IPF patients. METHODS:CD1c(+) myeloid DCs, BDCA3(high) myeloid DCs, BDCA2(+) plasmacytoid DCs and CD83(+) mature DCs were identified by flow cytometry in the BALF of 10 IPF patients and 10 controls. DC numbers were expressed as percentages of total BALF leukocytes. RESULTS:CD1c(+) myeloid DCs were increased in IPF patients versus controls [median (ranges in parentheses) 1.16% (0.25-3.97) vs. 0.61% (0.19-1.10), p = 0.01]. There was also a trend towards increased BDCA3(high) myeloid DCs [0.57% (0.23-0.88) vs. 0.28% (0.07-0.96), p = 0.07]. No differences were reported in BDCA2(+) DCs and CD83(+) DCs between IPF patients and controls. CONCLUSIONS: IPF is associated with an increase in percentages of BALF myeloid DCs. Considering that such an increase was not observed in CD83(+) mature DCs, most of these DCs should be immature.
Authors: Amanda M Burkhardt; Kenneth P Tai; Juan P Flores-Guiterrez; Natalia Vilches-Cisneros; Karishma Kamdar; Oralia Barbosa-Quintana; Ricardo Valle-Rios; Peter A Hevezi; Joaquin Zuñiga; Moises Selman; André J Ouellette; Albert Zlotnik Journal: J Immunol Date: 2012-05-18 Impact factor: 5.422
Authors: Tianju Liu; Hyun Ah Baek; Hongfeng Yu; Ho Jin Lee; Byung-Hyun Park; Matthew Ullenbruch; Jianhua Liu; Taku Nakashima; Yoon Young Choi; Gary D Wu; Myoung Ja Chung; Sem H Phan Journal: J Immunol Date: 2011-05-20 Impact factor: 5.422
Authors: Huan Liu; Claudia Jakubzick; Andrew R Osterburg; Rebecca L Nelson; Nishant Gupta; Francis X McCormack; Michael T Borchers Journal: Am J Respir Cell Mol Biol Date: 2017-10 Impact factor: 6.914
Authors: Alexandra M Greer; Michael A Matthay; Jasleen Kukreja; Nirav R Bhakta; Christine P Nguyen; Paul J Wolters; Prescott G Woodruff; John V Fahy; Jeoung-Sook Shin Journal: PLoS One Date: 2014-06-10 Impact factor: 3.240